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Objectives The study sought to describe a specific syndrome characterized by isolated left bundle branch block (LBBB) and a
history of progressive left ventricular (LV) dysfunction, successfully treated by cardiac resynchronization therapy (CRT).
Background Isolated LBBB in animals causes cardiac remodeling due to mechanical dyssynchrony, reversible by biventricular
stimulation. However, the existence of LBBB-induced cardiomyopathy in humans remains uncertain.
Methods Between 2007 and 2010, 375 candidates for CRT were screened and retrospectively included in this study if
they met all criteria of a pre-defined syndrome, including: 1) history of typical LBBB for 5 years; 2) LV ejection
fraction (EF) 50%; 3) decrease in LVEF to 40% and development of heart failure (HF) to NYHA functional
class II to IV over several years; 4) major mechanical dyssynchrony; 5) no known etiology of cardiomyopathy;
and 6) super-response to CRT with LVEF 45% and decrease in NYHA functional class at 1 year.
Results The syndrome was identified in 6 patients (1.6%), 50.5 years of age on average at the time of LBBB diagnosis.
HF developed over a mean of 11.6 years. At the time of referral, Doppler echocardiograms showed major me-
chanical dyssynchrony at left atrioventricular, interventricular, and left intraventricular levels. During CRT, NYHA
functional class decreased, LV dimensions normalized and mechanical dyssynchrony was nearly resolved in all
patients, and mean LVEF increased from 31  12% to 56  8% (p  0.027).
Conclusions These observations support the existence of a specific LBBB-induced cardiomyopathy resolved by CRT. Its preva-
lence, time course, and risk factors need to be prospectively studied. (J Am Coll Cardiol 2013;61:1089–95)
© 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.10.053t
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LThe prevalence of left bundle branch block (LBBB) in the
general population is approximately 1% (1). Occasionally
isolated (2), LBBB is more often associated with structural
heart disease. It is an independent predictor of cardiovas-
cular mortality and heart failure (HF) events, suggesting
that HF might develop as a result of LBBB (3,4). There is
firm evidence from clinical and experimental studies (5,6)
that LBBB induces abnormal left ventricular (LV) contrac-
tion and impairs global LV function, which might cause
progressive LV remodeling and HF. In addition, cardiac
resynchronization therapy (CRT) is a major means of
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accepted October 28, 2012.reverse remodeling and protection against HF events in pa-
tients presenting with typical LBBB (7,8), one of the most
powerful predictors of a super-response to CRT (9). Though
he clinical evidence remains weak, these observations support
he existence of a LBBB-induced cardiomyopathy (10). In
bsence of a prospective registry to assess the natural history of
solated LBBB, we hypothesized that the most persuasive
vidence would be provided by well-documented clinical cases,
llustrative of an original syndrome including a history of
BBB and LV dysfunction, reversed by CRT.
See page 1096
Methods
Patient population. Patients scheduled to undergo CRT
between 2007 and 2010 were included in this single-center
observational study if they presented with all characteristics
of a syndrome, including: 1) normal sinus rhythm and
5-year history of typical LBBB (11); 2) LV ejection
fraction (EF) 50% at the time of diagnosis of LBBB;
3) progressive decrease in LVEF to 40%; LV end-diastolic
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ment of New York Heart Asso-
ciation (NYHA) functional class
II to IV; 4) presence of major left
heart mechanical dyssynchrony;
5) no other identifiable cause of
cardiomyopathy (12); and 6) in-
dication for (13), and super-
response to, CRT, defined as a
LVEF 45% and decrease in
NYHA functional class within
12 months.
Data collection. The onset of
LBBB and history of LV function were retrospectively
ascertained by review of medical records.
ELECTROCARDIOGRAM. The 12-lead surface electrocar-
iograms were recorded at 25 mm/s during spontaneous
hythm, before implantation and after 12 months of
iventricular pacing, and analyzed by 2 independent
bservers. The QRS duration was measured as previously
eported (8).
ECHOCARDIOGRAPHY AND CARDIAC DYSSYNCHRONY. Tr-
ansthoracic echocardiograms were recorded before (baseline)
and after 12 months of CRT, using a ViVid Seven system
GE Healthcare, Milwaukee, Wisconsin). The LV dimensions
ere recorded using 2-dimensional echocardiogram-directed
-mode, and analyzed by 2 independent observers. LVEF
as estimated by LV biplane Simpson’s method. LV contrac-
ile function was analyzed by speckle tracking, using global
ongitudinal strain (14).
Left atrioventricular dyssynchrony was defined as a LV
lling time/R-R interval ratio 40%, and interventricular
yssynchrony as a 45 ms interval between pre-aortic and
re-pulmonary ejection times (15). Intra-LV dyssynchrony
as first ascertained by M-mode echocardiography, in
earch of “septal flash,” defined as a systolic stretch occur-
ing after initial shortening of the early activated septum
16). Using the B-mode speckle tracking software (17),
yssynchrony was ascertained as the delay between the
arliest and latest peaks of longitudinal strain recorded in
he mid-segment of the lateral and septal walls in the apical
-chamber view, and radial strain recorded in the antero-
eptal and posterior walls in the parasternal short axis view.
ntra-LV dyssynchrony was defined as a 130 ms delay, a
eak strain occurring after the aortic valve closure, or both.
mplantation and programming of the CRT systems.
he CRT devices were implanted transvenously. The right
entricular lead was placed preferentially in the mid-septum.
he LV lead was placed in a lateral or posterolateral
ributary of the coronary sinus. Systematic efforts were made
o obtain the narrowest biventricular paced QRS during the
mplant procedure and initial programming.
tatistical analyses. Individual data are reported because of
he small sample size. Paired measurements before and after
Abbreviations
and Acronyms
CRT  cardiac
resynchronization therapy
EF  ejection fraction
HF  heart failure
LBBB  left bundle branch
block
LV  left ventricular
NYHA  New York Heart
Association2 months of CRT were compared, using nonparametricilcoxon test for quantitative variables and McNemar test
or qualitative variables. A p value 0.05 was considered
ignificant.
esults
nitial observations. Among 375 recipients of CRT sys-
ems during the study period, 6 patients (1.6 %) ranging in
ge between 36 and 60 years had the pre-defined compo-
ents of the syndrome including super-responses to CRT
Fig. 1). The main characteristics of the 3 women and 3
en at the time of LBBB diagnosis are shown in Table 1.
he indication for the qualifying electrocardiogram was
hest pain in 2, and undetermined in 4 asymptomatic
atients. LBBB was intermittent and rate-dependent in 2
atients, before becoming permanent within 1 and 3 years,
espectively. The mean intrinsic QRS duration was 137 
1 ms. The baseline LVEF was 50% in all patients.
Symptoms consistent with HF developed within a mean
f 11.6 years (range 5 to 21 years) after LBBB diagnosis. All
atients reported chest pain on exertion. Combined treat-
ent with an angiotensin-converting enzyme inhibitor and
Figure 1 Patient Screening Process
Flow of patients from the screening to the selection of the final patient. *Left ven-
tricular ejection fraction (LVEF) 45% and 1 point decrease in New York Heart
Association (NYHA) class. CRT  cardiac resynchronization therapy; HF  heart
failure; LBBB  left bundle branch block.
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March 12, 2013:1089–95 CRT for LBBB-Induced Cardiomyopathybeta-adrenergic blocker was initiated in 5 patients, and a
beta-adrenergic blocker alone in 1 patient.
Time to referral for CRT. The persistence, despite optimal
medical therapy, of symptoms consistent with NYHA func-
tional class II in 2, and class III in 4 patients, prompted the
decision to proceed with CRT. The mean delay between the
first manifestations of HF and the CRT implant ranged
between 6 months and 12 years. At the time of referral, the
intrinsic QRS duration was 150 ms in all patients (Fig. 2).
Coronary angiography was normal in 5 patients, while the
distal right coronary artery was occluded with collateral circu-
lation from the left anterior descending artery in 1 patient.
Detailed, pre-implant echocardiographic studies showed evi-
dence of mechanical dyssynchrony at the left atrioventricular
(LV filling time/R-R ratio: 20% to 36%), interventricular
(mechanical delay: 57 to 111 ms), and intra-LV (longitudinal
and radial strain) levels (Table 2). The characteristics of
dyssynchrony were similar among patients.
Post-CRT evolution. An improvement in functional sta-
tus was observed within 3 months in 5, and within 6
months in 1 patient. At 1 year, 4 patients were in NYHA
functional class I, while in 2 patients it had decreased from
Main Characteristics of Individual PatientsTable 1 Main Characteristics of Individual Patients
Patient # Sex/Age
At Time of LBBB Diagnosis
Chest Pain as
First
Symptom
Rate-Related
LBBB
Intrinsic QRS
Duration
(ms)
QRS
Axis
1 M/36   160 65
2 M/41   150 61
3 F/51   120† 15
4 F/51   140 30
5 M/56   100† 15
6 F/60   155 14
*Before cardiac resynchronization therapy (CRT) implantation. †Patients with intermittent left bu
D  defibrillator; P  pacemaker.
Figure 2 QRS Morphology on Surface Electrocardiography
Surface electrocardiography in leads I, III, V1, and V6 during
intrinsic conduction showing typical pattern of left bundle branch block.CIII to II. Individual QRS and echocardiographic measure-
ments are shown before and after 12 months of CRT in
Table 2 and Figure 3. Mean QRS duration decreased by 29
s with CRT (p  0.027). Mean LVEF increased from
1 12% before CRT to 56 8% after 12 months of CRT
p  0.027), while the mean time to reach 45% was 7
months (range 3 to 12 months). Mean LV end-diastolic
diameter decreased from 64  14 mm to 52  5 mm (p 
.027) (Fig. 3). At 12 months, the echocardiographic signs
f atrioventricular mechanical dyssynchrony had disap-
eared in all patients, while minor signs of interventricular
yssynchrony persisted in 1 patient. The septal flash, pres-
nt before CRT in 4 patients, resolved in all 4 patients.
onsistent with the similar dyssynchrony pattern observed
efore CRT, the response to CRT was similar among
atients (Fig. 4), with a more homogeneous deformation of
he LV segments, reaching its peak at the time of aortic
alve closure, except in 1 patient, in whom the peak of
eformation occurred 10 ms later.
Over a mean follow-up of 36 months (range 16 to 56
onths), no patient died or suffered a major adverse clinical
vent, including hospitalization for management of HF.
iscussion
he patients included in this study, who presented with a
ong history of apparently isolated LBBB and progressive
V dysfunction, possessed the characteristics of an original
yndrome suspected from previous animal experiments,
pidemiological studies, and clinical observations, though
ever demonstrated in individual patients. These original
bservations strongly support the concept of LBBB-induced
ardiomyopathy treatable with CRT.
Isolated LBBB causes abnormalities of LV dysfunction,
anifest by a shortening of the filling time, a decreased
eptal contribution to LV ejection, and a globally depressed
F, compared with normal matched controls (5). High-
mplitude oscillations of the interventricular septum were
lso described, similar to the “septal flash,” a sign of
echanical dyssynchrony (present in 4 of our 6 patients)
nd a putative predictor of echocardiographic response to
Follow-Up
Between Diagnosis of
BBB and Onset of
Failure Symptoms (yrs)
Time Between Diagnosis
of LBBB and CRT
System Implant (yrs)
Intrinsic QRS
Duration
(ms)*
Implanted
System
7 19 175 CRT-D
21 22 150 CRT-D
17 18 155 CRT-P
9 9 160 CRT-P
11 11 160 CRT-D
5 5 155 CRT-P
nch block (LBBB).Time
L
HeartRT (16).
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proposed to detect and quantify LBBB-induced mechanical
dyssynchrony remains controversial, as they have failed to
Individual Electrocardiographic and Echocardiographic Measuremenof Cardi c R syn hronizationTable 2 Individual Electro ardiographic and Echo ardiographicof Cardiac Resynchronization
1 2
QRS duration, ms
Before 175 150
After 120 120
Left ventricular
Ejection fraction, %
Before 20 26
After 46 60
End-diastolic diameter, mm
Before 76 67
After 57 57
End-diastolic volume, ml
Before 313 231
After 152 164
Filling time/R-R interval, %
Before 25 53
After 47 57
Pre-ejection interval, ms
Before 69 111
After 39 30
Anteroseptal-post time to peak strain delay, ms
Before 363 150
After 17 43
Septolateral time to peak strain delay, ms
Before 394 228
After 22 22
Longitudinal global strain, %
Before 7 6
After 11 12
NA  not available; NS  not significant.
Figure 3 Individual Changes After 12 Months of CRT
Changes in QRS duration, LVEF, and LV end-diastolic diameter between before anpredict the response to, and improve the patient selection
for CRT (18). Our assessment of mechanical dyssynchrony
was for a different objective. Mechanical dyssynchrony, the
efore and After 12 Monthssureme ts Before and After 12 Months
Patient #
Mean  SD p Value4 5 6
160 160 155 159 9
0.027
120 135 130 123 9
33 40 37 31 7
0.027
62 63 58 56 8
55 56 56 62 14
0.027
48 48 50 52 12
100 NA 100 191 91
NS
102 78 107 126 35
25 NA 36 32 13
0.043
65 47 43 52 8
91 NA 110 88 24
0.043
7 18 46 31 16
311 NA 177 243 90
0.043
26 25 29 27 9
301 NA 246 303 69
0.043
26 45 15 24 11
8 NA 12 8 2
0.043
18 13 15 14 3
12 months of CRT. Abbreviations as in Figure 1.ts BMea
3
155
110
29
45
60
50
211
154
20
55
57
47
218
22
347
16
6
12d after
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(A) Patient #1: dyssynchrony assessed by Doppler echocardiography. Atrioventricular and interventricular dyssynchrony alleviated by CRT. (B) Patient #1: dyssynchrony
assessed by 2-dimensional strain speckle tracking (radial and longitudinal deformation). Intra-LV dyssynchrony alleviated by CRT. Abbreviations as in Figure 1.
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dysfunction, is at the root of LBBB-induced cardiomyopa-
thy. We used several techniques to assess dyssynchrony at
multiple levels, combining simple and reproducible
Doppler-echocardiographic measurements of LV filling
time and intraventricular mechanical delay (15), and
2-dimensional strain for the intra-LV analysis (17). This
revealed that mechanical dyssynchrony was present at all
levels in all patients, and the pattern of dyssynchrony and its
alleviation by CRT was similar among patients.
In animal experiments, a link was found between LBBB,
mechanical dyssynchrony and LV dysfunction, whereby
isolated LBBB induces functional septal hypoperfusion and
progressive ventricular remodeling (6). A mean 23% de-
crease in LVEF and 25% increase in LV end-diastolic
volume, associated with a regional redistribution of circum-
ferential shortening and myocardial blood flow was observed
at 8 weeks, in a canine model of isolated LBBB. In absence
of long-term, serial echocardiographic studies in patients
with isolated LBBB, whether similar changes occur in
humans remains unclear. In case control studies, LV dila-
tation and decrease in LVEF were greater in patients
presenting with chronic LBBB than in controls (19). How-
ever, whether this prominent remodeling is the consequence
of LBBB, or whether LBBB is a marker of a more
progressive disease, remains unclear.
In the animal model of isolated LBBB, 8 weeks of
biventricular stimulation largely reversed the functional and
structural LV abnormalities (20), an observation concordant
with observations made in controlled trials, where the
decreases in echocardiographic LV volumes and increase
in LVEF were significantly greater in CRT recipients
with than without LBBB (8,9). While it strengthens the
hypothesis that LBBB might be a “reversible cause of
nonischemic cardiomyopathy with severe HF” (10), it
does not prove it.
Our patients’ histories of LBBB and LV dysfunction
strongly support the concept of LBBB-induced cardiomy-
opathy. As observed in animals (6), persistent mechanical
ventricular dyssynchrony caused by isolated LBBB might
induce progressive LV dysfunction and chronic HF in
humans. Complete or nearly complete recovery of cardiac
mechanical function by CRT is further support of the
concept, as the treatment of dyssynchrony alone cured the
cardiomyopathy. This might explain the various re-
sponses to CRT among the different types of dilated
cardiomyopathy as well as the profile of certain “super-
responders.”
Study limitations. The aim of this retrospective analysis
was to describe a putative LBBB-induced cardiomyopathy,
perhaps curable by CRT. While our methodology did not
allow a precise measurement of the prevalence of the
syndrome, we believe that the 1.6% observed in our study is
an underestimation due to the retrospective data collection
and missing data. Indeed, in an undetermined proportion of
initially asymptomatic patients, LBBB may be a silent causeof “primary” dilated cardiomyopathy and HF particularly
responsive to CRT. The time needed for the syndrome to
develop and the factors promoting its development need to
be examined prospectively in patients presenting with iso-
lated LBBB, though the feasibility of such study is uncer-
tain. One might also hypothesize that, in an undetermined
proportion of patients, LBBB was the first manifestation of
a cardiomyopathy of unknown etiology, which slowly
evolved toward HF. This hypothesis finds support in the
failure of 2 of the 8 patients to “super-respond” to CRT.
Furthermore, because of the retrospective design of our
study, detailed evaluations of the patients with LBBB and a
“preserved” LV function were not available. Finally, the
proportion of patients with isolated LBBB who do not
develop HF and, therefore, do not become candidates for
CRT is unknown.
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